Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Paul, Hosking"'
Autor:
Nicole, Piscatelli, Nicole V, Hinchy, Jennifer, Frustino, Laura T, Reed, James, Zemer, Naheed, Alam, Paul, Hosking, Maureen A, Sullivan
Publikováno v:
General dentistry. 70(2)
This report presents a case in which oral soft tissue lesions were the first signs of multiple myeloma (MM) following a solid-organ transplantation. A 75-year-old man presented with bilateral primary oral gingival masses in the posterior mandible app
Autor:
Christopher P. Hartley, Jason A. Jarzembowski, Alexandra M. Harrington, Steven H. Kroft, Horatiu Olteanu, James Vaughan, Paul Hosking
Publikováno v:
American Journal of Clinical Pathology. 148:485-493
Objectives CD30 is a protein thought to promote cell proliferation/survival and downregulate the immune response. Twenty percent to 40% of de novo diffuse large B-cell lymphomas (DLBCLs) express CD30, and some patients have been treated with the anti
Publikováno v:
International journal of laboratory hematology. 41(1)
INTRODUCTION Carcinocythemia is a rare phenomenon defined as morphologically identifiable, circulating tumor cells in the peripheral blood. No modern case series of carcinocythemia exists in the literature. METHODS Blood smears from carcinocythemia p
Publikováno v:
JAAD Case Reports
For more than 30 years, methotrexate (MTX) has been a mainstay in the treatment of various inflammatory disorders including rheumatoid arthritis (RA) and psoriasis.1 Off-label use of MTX has expanded in recent years, as it is found to be effective in
Autor:
Ruta Brazauskas, Robert Schneidewend, Karen Carlson, Parameswaran Hari, Ehab Atallah, Laura C. Michaelis, Jess F. Peterson, Carlie Beaudin, Paul Hosking
Publikováno v:
Acta haematologica. 139(3)
Autor:
Steven H. Kroft, Alexandra M. Harrington, Bjorn Batdorf, Horatiu Olteanu, Alexander C. Mackinnon, Paul Hosking
Publikováno v:
Annals of diagnostic pathology. 29
Objectives CD43 is normally expressed only on the surface of leukocytes, and is considered a sensitive and specific marker for hematologic malignancies. As such, it may have diagnostic utility in confirming hematolymphoid lineage in cases that are ne
Publikováno v:
American Journal of Clinical Pathology. 150:S101-S102
INTRODUCTION Carcinocythemia is a rare phenomenon defined as morphologically identifiable, circulating tumor cells in the peripheral blood. No modern case series of carcinocythemia exists in the literature. METHODS Blood smears from carcinocythemia p
Autor:
Anjisnu Banerjee, Timothy S. Fenske, Malika Siker, Gerald J. Harris, Gregory J. Griepentrog, Beth Erickson, Narendranath Epperla, Parameswaran Hari, Timothy S. Wells, Sridevi Ramalingam, Mehdi Hamadani, Binod Dhakal, Paul Hosking, Jamie Shuff, Nirav N. Shah, Lisa Rein, Anita D'Souza
Publikováno v:
Clinical lymphoma, myelomaleukemia. 17(5)
Introduction Ocular adnexal lymphoproliferative disorders (OALDs) are almost exclusively of B-cell origin, with the majority being extra-nodal marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT). The comparative efficacy of involved f
Autor:
Steven H. Kroft, Atousa Ordobazari, Alexandra M. Harrington, Paul Hosking, Lindsay A. Schelling, Horatiu Olteanu
Publikováno v:
American journal of clinical pathology. 146(2)
Objectives: We sought to immunophenotype blasts, monocytes, and granulocytes in chronic myelomonocytic leukemias (CMMLs) and compare CMML subtypes, to identify if significant antigen expression differences existed. Methods: Bone marrow blasts, monocy
Autor:
Robert P. Hasserjian, Mark D. Ewalt, Paul Hosking, Dita Gratzinger, Susan E. Wheaton, Hongmei Li, Horatiu Olteanu, Alex J. Pildain, Alexandra M. Harrington, Steven H. Kroft
Publikováno v:
American journal of clinical pathology. 145(4)
Objectives: Pure erythroid leukemia (PEL) is an extremely rare entity that may, even more rarely, evolve from a preexisting chronic myeloid neoplasm (CMN); there is minimal literature regarding this latter phenomenon. Methods: We describe 14 patients